METHYCLOTHIAZIDE; RESERPINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methyclothiazide; reserpine and what is the scope of patent protection?
Methyclothiazide; reserpine
is the generic ingredient in one branded drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for METHYCLOTHIAZIDE; RESERPINE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | METHYCLOTHIAZIDE; RESERPINE at DailyMed |
US Patents and Regulatory Information for METHYCLOTHIAZIDE; RESERPINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medpointe Pharm Hlc | DIUTENSEN-R | methyclothiazide; reserpine | TABLET;ORAL | 012708-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |